The role of sulfonylureas in type 2 diabetes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1301, 2001-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus

By Swen Jesse J   Wessels Judith AM   Krabben Annemarie   Assendelft Willem JJ   Guchelaar Henk-Jan  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1517-1523

Future Medicine

Access to resources Recommend Favorite

The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

By Rendell M.  

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1339-1358

Adis International

Access to resources Recommend Favorite

Update on sulfonylureas in diabetes

By  

Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Sulfonylureas may be associated with beneficial outcomes in patients with type II diabetes mellitus who experience an acute ischaemic stroke

By  

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Insulin glargine and its role in glycaemic management of Type 2 diabetes

By Elrishi MA   Jarvis J   Khunti K   Davies MJ  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1099-1110

Informa Healthcare

Access to resources Recommend Favorite